ain Content

MCX, India’s largest commodity derivatives exchange, delivered a quarter that looked exceptional on paper. The stock, however, fell sharply.

On Wednesday, November 4, 2026, MCX shares dropped as much as 7% to an intraday low of ₹3,252.50 on the BSE, snapping a two-day winning streak. The previous session, the stock had closed at ₹3,490.10 after surging 7.4% ahead of the earnings announcement .

The sell-off came despite a blockbuster Q2 FY27 report: consolidated net profit more than doubled to ₹454.57 crore, up 130% year-on-year from ₹197.47 crore. Revenue from operations surged 114% to ₹799.66 crore. EBITDA jumped 151% to ₹611.24 crore, with margins expanding to 76.4% from 65.1% a year earlier .

So why did the stock fall?

Reason 1: Profit-Taking After a Massive Run

MCX shares had rallied over 50% in 2026 before the results, hitting a fresh 52-week high of ₹3,537 on Tuesday. The stock had gained 53% year-to-date and 80% over the past year .

When a stock runs up that much into an earnings event, even a good result often triggers selling. SBI Securities’ head of fundamental research, Sunny Agrawal, put it plainly: “Today’s street reaction is kind of profit booking post strong pre-result rally” .

The technical picture supports this. MCX had formed a reverse symmetrical triangle pattern and was trading near its upper boundary, where it faced resistance around ₹3,538. The stock was ripe for a pullback .

Reason 2: The Profit Miss Was Small But Real

The headline numbers looked great, but they fell slightly short of what analysts expected.

Jefferies noted that PAT came in 5% below its estimate, partly because the clearing arm booked H1’s ₹47 crore tax expense in Q2. Technology costs also grew faster than expected .

Morgan Stanley flagged that PAT was 3% below its estimate and 6% below Visible Alpha consensus, driven by a higher tax rate of 29%. Core EBITDA was 2% below estimate due to 8% higher operating expenses .

In a market where expectations were already elevated, a small miss is enough to trigger selling.

Reason 3: Valuation Was Already Rich

After the 2026 rally, MCX was trading at a valuation that left little room for error. Analysts cited “rich valuation” as a factor behind the profit-booking .

For a stock that had already priced in a lot of good news, the Q2 beat needed to be spectacular to justify further gains. It was strong, but not spectacular enough.

What Brokerages Are Saying

Despite the sell-off, major brokerages remain bullish. The consensus view: the business is compounding, and the dip is a technical correction, not a fundamental breakdown.

*Based on previous close of ₹3,490.10

Jefferies maintained its Buy rating, saying Q2 performance was “largely in line” with expectations. Revenue rose 14% sequentially, EBITDA grew 16%, and options now account for 76% of trading revenue .

Morgan Stanley stayed Overweight, noting that 3Q-to-date average daily traded revenue stood at ₹123 million, ahead of its FY27 estimate of ₹108.5 million. The brokerage remains positive on MCX’s “defensive positioning amid geopolitical uncertainty” .

SBI Securities described MCX as a “direct play on global commodity-price volatility” and expects the business to compound at 20-25% CAGR led by rising customer participation and options volume .

The Operational Strength Is Genuine

The Q2 numbers reflect real business momentum, not accounting tricks.

Average daily turnover for futures rose to ₹62,819 crore, while options turnover hit ₹12,00,129 crore. The exchange also handled physical deliveries of 5.68 metric tonnes of gold, 199.91 metric tonnes of silver, and 34,707 metric tonnes of base metals during the quarter .

MD and CEO Praveena Rai attributed the performance to “sustained growth across product segments, higher market participation and continued efforts to widen the product basket” .

What Should Investors Do?

For traders: The ₹3,200 level, which coincides with the 20-day EMA, is the key support to watch. A break below could trigger further selling. ₹3,225 is the immediate support level identified by analysts .

For long-term investors: The business fundamentals are intact. MCX dominates commodity derivatives trading in India, options volume is growing rapidly, and the exchange benefits directly from volatility in energy and bullion markets. The dip may offer an entry point, but the valuation remains rich. Staggered buying is more prudent than a lump-sum bet.

The key question for the next quarter: can options momentum sustain, and can the exchange expand margins further? If yes, the stock has room to reclaim its highs. If growth slows, the premium valuation will be hard to defend.

FAQ

Q1: Why did MCX shares fall despite strong Q2 results?
The stock fell due to profit-booking after a 50% rally in 2026, a small earnings miss versus analyst estimates (PAT 3-5% below expectations), and rich valuations that left little room for error .

Q2: What was MCX’s Q2 FY27 net profit?
Consolidated net profit more than doubled to ₹454.57 crore, up 130% year-on-year from ₹197.47 crore. Revenue rose 114% to ₹799.66 crore .

Q3: What are the brokerage target prices for MCX?
Jefferies has a Buy rating with a ₹4,000 target. Morgan Stanley is Overweight with ₹3,835. SBI Securities has a ₹3,633 target .

Q4: What is the key support level for MCX shares?
₹3,200, which aligns with the 20-day EMA, is the key support level. ₹3,225 is the immediate support to watch .